M. N. Khagazheeva
Blokhin National Medical Research Center of Oncology
Russian Federation

Madina N. Khagazheeva, Oncologist, Department of Antitumor Drug Therapy No. 3, Trapeznikov Research Institute of Clinical Oncology

24, Kashirskoye Shosse, Moscow, 115522

A. R. Zaretsky
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
Russian Federation

Andrew R. Zaretsky, Head of the Oncology Department, Schwartz Association of Specialists in Molecular Medicine, Laboratory and Clinical Genetics, Researcher, Laboratory of Immunosequencing and Genomics of Antitumor Immunity

16/10, Bldg. 1, MiklukhoMaklai St., Moscow, 117437

A. N. Koshmanova
Blokhin National Medical Research Center of Oncology
Russian Federation

Anna N. Koshmanova, Resident of the Department of Antitumor Drug Therapy No. 3, Trapeznikov Research Institute of Clinical Oncology

24, Kashirskoye Shosse, Moscow, 115522

I. A. Dzhanyan
Blokhin National Medical Research Center of Oncology
Russian Federation

Irina A. Dzhanyan, Oncologist, Department of Abdominal Oncology No. 5, Trapeznikov Research Institute of Clinical Oncology

24, Kashirskoye Shosse, Moscow, 115522

I. V. Savchenko
Blokhin National Medical Research Center of Oncology
Russian Federation

Ilya V. Savchenko, Oncologist, Department of Antitumor Drug Therapy No. 3, Trapeznikov Research Institute of Clinical Oncology

24, Kashirskoye Shosse, Moscow, 115522

E. Yu. Antonova
Blokhin National Medical Research Center of Oncology
Russian Federation

Elena Yu.Antonova, Oncologist, Department of Antitumor Drug Therapy No. 3,Trapeznikov Research Institute of Clinical Oncology

24, Kashirskoye Shosse, Moscow, 115522

K. K. Laktionov
Blokhin National Medical Research Center of Oncology; Pirogov Russian National Research Medical University
Russian Federation

Konstantin K. Laktionov, Dr. Sci. (Med.), Head of the Antitumor Drug Therapy Department No. 3, Drug Treatment Department, Blokhin National Medical Research Center of Oncology; 2rofessor, Department of Oncology and Radiation Therapy, Faculty of General Medicine, Pirogov Russian National Research Medical University

24, Kashirskoye Shosse, Moscow, 115522; 
1, Ostrovityanov St., Moscow, 117513

V. V. Breder
Blokhin National Medical Research Center of Oncology
Russian Federation

Valeriy V. Breder, Dr. Sci. (Med.), Head of the Treatment Department, Antitumor Drug Therapy Department No. 3, Trapeznikov Research Institute of Clinical Oncology

24, Kashirskoye Shosse, Moscow, 115522